SHA:688710 Revenue

In the year 2025, Shanghai InnoStar Bio-tech had annual revenue of 811.33M CNY, down -28.94%. Shanghai InnoStar Bio-tech had revenue of 240.64M in the quarter ending December 31, 2025, a decrease of -7.17%.

Revenue

811.33M

Revenue Growth

-28.94%

P/S Ratio

11.81

Revenue / Employee

747.77K

Employees

1,092

Market Cap

9.58B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	811.33M	-330.34M	-28.94%
Dec 31, 2024	1.14B	103.24M	9.94%
Dec 31, 2023	1.04B	175.36M	20.32%
Dec 31, 2022	863.07M	281.30M	48.35%
Dec 31, 2021	581.77M	248.00M	74.30%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Zhejiang Jolly Pharmaceutical Co.,LTD	3.11B
GuangYuYuan Chinese Herbal Medicine	1.44B
Yifan Pharmaceutical	5.06B
Aurora Optoelectronics	465.12M
Nanjing Pharmaceutical Group Company	54.96B
CSPC Hunan Jingfeng Pharmaceutical	393.19M
Zhejiang Wolwo Bio-Pharmaceutical	1.09B
Chongqing Lummy Pharmaceutical	759.50M

Revenue Rankings